Geron Corp (GERN)
3.79
+0.23
(+6.46%)
USD |
NASDAQ |
Apr 26, 16:00
3.78
-0.01
(-0.26%)
After-Hours: 19:17
Geron Cash from Operations (Quarterly): -40.94M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -40.94M |
September 30, 2023 | -50.84M |
June 30, 2023 | -29.60M |
March 31, 2023 | -46.36M |
December 31, 2022 | -35.18M |
September 30, 2022 | -29.58M |
June 30, 2022 | -28.64M |
March 31, 2022 | -33.97M |
December 31, 2021 | -22.17M |
September 30, 2021 | -22.84M |
June 30, 2021 | -17.81M |
March 31, 2021 | -32.73M |
December 31, 2020 | -12.61M |
September 30, 2020 | -15.45M |
June 30, 2020 | -12.40M |
March 31, 2020 | -26.19M |
December 31, 2019 | -10.37M |
September 30, 2019 | -11.98M |
June 30, 2019 | -8.745M |
March 31, 2019 | -12.74M |
December 31, 2018 | -3.01M |
September 30, 2018 | -6.136M |
June 30, 2018 | -4.495M |
March 31, 2018 | -7.368M |
December 31, 2017 | -4.387M |
Date | Value |
---|---|
September 30, 2017 | -4.424M |
June 30, 2017 | -4.438M |
March 31, 2017 | -7.307M |
December 31, 2016 | -0.602M |
September 30, 2016 | -6.553M |
June 30, 2016 | -5.636M |
March 31, 2016 | -5.578M |
December 31, 2015 | -5.251M |
September 30, 2015 | -4.905M |
June 30, 2015 | -6.335M |
March 31, 2015 | -7.705M |
December 31, 2014 | 28.48M |
September 30, 2014 | -4.472M |
June 30, 2014 | -5.15M |
March 31, 2014 | -9.505M |
December 31, 2013 | -6.801M |
September 30, 2013 | -5.725M |
June 30, 2013 | -7.927M |
March 31, 2013 | -16.23M |
December 31, 2012 | -10.42M |
September 30, 2012 | -14.38M |
June 30, 2012 | -13.76M |
March 31, 2012 | -16.58M |
December 31, 2011 | -21.37M |
September 30, 2011 | -14.27M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-50.84M
Minimum
Sep 2023
-8.745M
Maximum
Jun 2019
-25.71M
Average
-26.19M
Median
Mar 2020
Cash from Operations (Quarterly) Benchmarks
Madrigal Pharmaceuticals Inc | -79.93M |
SELLAS Life Sciences Group Inc | -4.825M |
Johnson & Johnson | 7.863B |
Immuneering Corp | -11.78M |
Moderna Inc | 622.00M |
Cash from Operations (Quarterly) Related Metrics
Cash from Investing (Quarterly) | 47.57M |
Cash from Financing (Quarterly) | 33.28M |
Free Cash Flow | -168.57M |
Free Cash Flow Per Share (Quarterly) | -0.0689 |
Free Cash Flow to Equity (Quarterly) | -71.05M |
Free Cash Flow Yield | -7.85% |